TORRIGIANI GINEVRA

Ojeda-Fernandez, L., Calvisi, S., Torrigiani, G., Tettamanti, M., Fortino, I., Roncaglioni, C., et al. (2025). Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study. RHEUMATOLOGY, 64(5), 2723-2730 [10.1093/rheumatology/keae496]. Detail

Baviera, M., Foresta, A., Fernandez, L., Torrigiani, G., Tettamanti, M., Roncaglioni, M., et al. (2025). Peripheral artery disease in patients with stable coronary artery disease in general practice: results from an Italian nationwide study—PAD & CAD study. INTERNAL AND EMERGENCY MEDICINE, 20(1 (January 2025)), 159-169 [10.1007/s11739-024-03771-9]. Detail

Colaneri, M., Canuti, M., Torrigiani, G., Dall'Olio, L., Bobbio, C., Baldi, S., et al. (2025). Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2. INFECTIOUS DISEASES AND THERAPY, 14(2), 447-461 [10.1007/s40121-024-01107-w]. Detail

Franchi, M., Torrigiani, G., Kjeldsen, S., Mancia, G., Corrao, G. (2024). Long-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study. JOURNAL OF HYPERTENSION, 42(12), 2107-2114 [10.1097/HJH.0000000000003841]. Detail

Foresta, A., Fernandez, L., Torrigiani, G., Schena, S., Roncaglioni, M., Nobili, A., et al. (2024). Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study. DRUGS & AGING, 41(3), 239-249 [10.1007/s40266-024-01097-x]. Detail